布仑妥昔单抗维多汀
医学
霍奇金淋巴瘤
内科学
肿瘤科
淋巴瘤
作者
Andres Forero‐Torres,Beata Holkova,Jerome H. Goldschmidt,Robert Chen,Gregg A. Olsen,Ralph V. Boccia,Rodolfo Bordoni,Jonathan W. Friedberg,Jeff P. Sharman,Maria Corinna Palanca-Wessels,Yinghui Wang,Christopher A. Yasenchak
出处
期刊:Blood
[Elsevier BV]
日期:2015-09-16
卷期号:126 (26): 2798-2804
被引量:135
标识
DOI:10.1182/blood-2015-06-644336
摘要
Key Points Frontline brentuximab vedotin monotherapy provided a 92% ORR and was generally well tolerated in elderly HL patients.
科研通智能强力驱动
Strongly Powered by AbleSci AI